Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).

[1]  R. Izumi,et al.  [Ovarian epithelial tumors of borderline malignancy]. , 1992, Rinsho byori. The Japanese journal of clinical pathology.

[2]  J. Berek,et al.  Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Bostwick,et al.  Ovarian epithelial tumors of borderline malignancy: A clinical and pathologic study of 109 cases , 1986, Cancer.

[4]  E. Hannigan,et al.  Epithelial ovarian neoplasms of low malignant potential. , 1985, Gynecologic oncology.

[5]  R. Park,et al.  Epithelial Ovarian Carcinoma of Low Malignant Potential , 1985, Obstetrics and gynecology.

[6]  T. Colgan,et al.  Ovarian Epithelial Tumors of Low Malignant Potential: A Review , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  P. Disaia,et al.  Stage I Borderline Ovarian Tumors , 1982, Obstetrics and gynecology.

[8]  T. E. Morgan,et al.  Proliferative serous tumors of the ovary: Histologic features and prognosis , 1978, The American journal of surgical pathology.

[9]  Woodruff Jd,et al.  The biologic behavior of low-grade papillary serous carcinoma of the ovary. , 1972 .

[10]  P. Kolstad,et al.  Clinical and Histologic Studies of Ovarian Carcinoma: Long - Term Follow - Up of 990 Cases , 1971, Obstetrics and gynecology.

[11]  H. Kottmeier,et al.  General Classification of Ovarian Tumours , 1968 .

[12]  J. Varangot.  [General classification of ovarian tumors]. , 1965, La Revue du praticien.